Target Name: OR10D3
NCBI ID: G26497
Review Report on OR10D3 Target / Biomarker Content of Review Report on OR10D3 Target / Biomarker
OR10D3
Other Name(s): OR10D3P | Olfactory receptor, family 10, subfamily D, member 3 (non-functional) | seven transmembrane helix receptor | HTPCRX09 | olfactory receptor OR11-293 | olfactory receptor family 10 subfamily D member 3 (putative) | olfactory receptor, family 10, subfamily D, member 3 (non-functional) | olfactory receptor, family 10, subfamily D, member 3 pseudogene | olfactory receptor family 10 subfamily D member 3

OR10D3: A Protein as A Drug Target

OR10D3 (OR10D3P) is a protein that is expressed in various tissues of the body, including the brain, pancreas, and gastrointestinal tract. It is a member of the OR10 family of transmembrane proteins, which are characterized by their ability to span the cell membrane and interact with various intracellular signaling pathways. OR10D3 has been shown to play a role in several cellular processes, including cell signaling, cell adhesion, and tissue repair.

One of the most promising aspects of OR10D3 is its potential as a drug target. OR10D3 has been shown to interact with several signaling pathways, including the TGF-β pathway. This pathway is involved in several cellular processes, including cell growth, differentiation, and survival. Therefore, targeting OR10D3 with small molecules or antibodies that can modulate its activity could be a promising strategy for the development of new treatments for a variety of diseases.

One approach to targeting OR10D3 is to use small molecules that can modulate its activity. One class of small molecules that have been shown to interact with OR10D3 is called IDH inhibitors. IDH (inositol hexa-phosphate) is a critical intracellular signaling molecule that is involved in cell growth, proliferation, and survival. OR10D3 has been shown to interact with IDH, and inhibiting its activity has been shown to be a potential strategy for targeting OR10D3.

Currently, there are already some IDH inhibitors, such as Oxiracetam, Vogelzumab, and Nirupimavir, which have shown good pharmacological activity in preclinical studies and can be used as potential OR10D3 Drug targets. In addition, the researchers also discovered some other molecules that may interact with OR10D3, such as CDK4, PDGF receptors, etc., and these molecules may also become potential drug targets for OR10D3.

In addition to small molecule compounds, the researchers also studied the biological functions of OR10D3 to understand its role in cell signaling and cell adhesion. Studies have shown that OR10D3 is expressed in multiple cell types and participates in multiple signaling pathways, such as Notch, FGFR and EGFR. At the same time, OR10D3 is also related to cell adhesion and migration, such as adhesion mediated through cell-matrix connection and cell-cell channel.

In addition, the role of OR10D3 in tissue repair and regeneration has also attracted much attention. Studies have shown that OR10D3 is expressed in a variety of regenerative objects, such as mouse skin, mouse liver, and mouse bones. In studies of mouse skin injury models, deletion of OR10D3 significantly inhibited the wound healing process. These results indicate that OR10D3 plays an important role in tissue repair and regeneration, and therefore has important clinical prospects as a drug target.

In summary, OR10D3 is a protein with a wide range of biological activities, and its pharmacological activity is of high value in small molecule compounds and antibody-targeted therapies. In the future, researchers will continue to study the biological functions of OR10D3 to explore its potential as a drug target and develop more effective treatments.

Protein Name: Olfactory Receptor Family 10 Subfamily D Member 3

Functions: Odorant receptor

The "OR10D3 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about OR10D3 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

OR10D4P | OR10G2 | OR10G3 | OR10G4 | OR10G7 | OR10G8 | OR10G9 | OR10H1 | OR10H2 | OR10H3 | OR10H4 | OR10H5 | OR10J1 | OR10J2P | OR10J3 | OR10J5 | OR10K1 | OR10K2 | OR10P1 | OR10Q1 | OR10R2 | OR10S1 | OR10T2 | OR10V1 | OR10W1 | OR10X1 | OR10Z1 | OR11A1 | OR11G2 | OR11H1 | OR11H12 | OR11H13P | OR11H2 | OR11H5P | OR11H6 | OR11H7 | OR11J2P | OR11J5P | OR11K2P | OR11L1 | OR11M1P | OR12D2 | OR12D3 | OR13A1 | OR13C2 | OR13C3 | OR13C4 | OR13C5 | OR13C8 | OR13C9 | OR13D1 | OR13F1 | OR13G1 | OR13H1 | OR13J1 | OR13Z2P | OR14A16 | OR14A2 | OR14C36 | OR14I1 | OR14J1 | OR14L1P | OR1A1 | OR1A2 | OR1B1 | OR1C1 | OR1D2 | OR1D4 | OR1D5 | OR1E1 | OR1E2 | OR1E3 | OR1F1 | OR1F2P | OR1G1 | OR1I1 | OR1J1 | OR1J2 | OR1J4 | OR1K1 | OR1L1 | OR1L3 | OR1L4 | OR1L6 | OR1L8 | OR1M1 | OR1N1 | OR1N2 | OR1P1 | OR1Q1 | OR1S1 | OR1S2 | OR2A1 | OR2A1-AS1 | OR2A12 | OR2A14 | OR2A2 | OR2A20P | OR2A25 | OR2A4